Search Results 451-460 of 1887 for 搜索引擎平台开发咨询邮箱：lgooxc@hotmail.com
Monoclonal antibodies, such as nivolumab and brentuximab vedotin, may interfere with the ability of cancer cells to grow and spread. Participation eligibility.
About this study. The purpose of this study is to evaluate a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL).
The purpose of this study is to evaluate the effectiveness of MK-7240 compared to Placebo as assessed by the proportion of participants achieving clinical ...
The purpose of this study is to evaluate the long-term safety and tolerability of cenobamate adjunctive therapy in subjects with primary generalized tonic- ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
bb2121 is administered in subjects 1 time (or retreated if retreatment criteria are met) in parent clinical study. No investigational treatment will be ...
Duloxetine increases the amount of certain chemicals in the brain that help relieve depression and pain. Giving duloxetine in patients undergoing treatment with ...
About this study. The main purpose of this study is to measure overall activity (inactive to high intensity) during a 12-week cardiac rehabilitation program ...
Contact Dr. Radisky in the Tumor Microenvironment Lab at Mayo Clinic about his research on matrix metalloproteinases, transcriptional profiling and ...
Blood brain barrier is an obstacle in treatment of brain tumors such as CNS lymphoma. Pomalidomide was shown to have an excellent CNS penetration in a murine ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.